Role of E166 in the imine to enamine tautomerization of the clinical beta-lactamase inhibitor sulbactam.

Biochemistry

Department of Biochemistry, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA.

Published: November 2009

Mechanism-based inhibitors of class A beta-lactamases, such as sulbactam, undergo a complex series of chemical reactions in the enzyme active site. Formation of a trans-enamine acyl-enzyme via a hydrolysis-prone imine is responsible for transient inhibition of the enzyme. Although the imine to enamine tautomerization is crucial to inhibition of the enzyme, there are no experimental data to suggest how this chemical transformation is catalyzed in the active site. In this report, we show that E166 acts as a general base to promote the imine to enamine tautomerization.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783953PMC
http://dx.doi.org/10.1021/bi901416tDOI Listing

Publication Analysis

Top Keywords

imine enamine
12
enamine tautomerization
12
active site
8
inhibition enzyme
8
role e166
4
imine
4
e166 imine
4
tautomerization clinical
4
clinical beta-lactamase
4
beta-lactamase inhibitor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!